GL1X · GenesisL1 explorer

UniProt P03366

Reverse transcriptase/ribonuclease H (P03366)

Reverse transcriptase/ribonuclease H (UniProt P03366), EC 2.7.7.-, 2.7.7.49: 617 experimental structures on GenesisL1, 110 ligands bound, 1,661 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P03366
Protein
Reverse transcriptase/ribonuclease H
EC
2.7.7.-, 2.7.7.49, 2.7.7.7, 3.1.-.-, 3.1.13.2, 3.1.26.13, 3.1.26.4, 3.4.23.16
Experimental structures
617
Predicted models
0
Ligands
110
Pockets
1,661 · 106 records with a druggable one

Structures

617 records of P03366 in the MolNFT archive: 617 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1AJVHIV-1 protease in complex with the cyclic sulfamide inhibitor AHA006x-ray diffractionA, B——
1AJVHIV-1 protease in complex with the cyclic sulfamide inhibitor AHA006x-ray diffractionA, B——
1AJXHIV-1 protease in complex with the cyclic urea inhibitor AHA001x-ray diffractionA, B——
1AJXHIV-1 protease in complex with the cyclic urea inhibitor AHA001x-ray diffractionA, B——
1AXAActive-site mobility in human immunodeficiency virus type 1 protease as demonstrated by crystal…x-ray diffractionA, B——
1AXAActive-site mobility in human immunodeficiency virus type 1 protease as demonstrated by crystal…x-ray diffractionA, B——
1BQMHIV-1 RT/HBY 097x-ray diffractionA, B——
1BQMHIV-1 RT/HBY 097x-ray diffractionA, B——
1BQNTyr 188 leu HIV-1 RT/HBY 097x-ray diffractionA, B——
1BQNTyr 188 leu HIV-1 RT/HBY 097x-ray diffractionA, B——
1D4HHIV-1 Protease in complex with the inhibitor BEA435x-ray diffractionA, B——
1D4HHIV-1 protease in complex with the inhibitor BEA435x-ray diffractionA, B——
1D4IHIV-1 protease in complex with the inhibitor BEA425x-ray diffractionA, B——
1D4IHIV-1 protease in complex with the inhibitor BEA425x-ray diffractionA, B——
1D4JHIV-1 protease in complex with the inhibitor MSL370x-ray diffractionA, B——
1D4JHIV-1 protease in complex with the inhibitor MSL370x-ray diffractionA, B——
1DLOHuman immunodeficiency virus type 1x-ray diffractionA, B——
1DLOHuman immunodeficiency virus type 1x-ray diffractionA, B——
1DW6Structural and kinetic analysis of drug resistant mutants of HIV-1 proteasex-ray diffractionC, D——
1DW6Structural and kinetic analysis of drug resistant mutants of HIV-1 proteasex-ray diffractionC, D——
1EBKStructural and kinetic analysis of drug resistant mutants of HIV-1 proteasex-ray diffractionC, D, E, F——
1EBKStructural and kinetic analysis of drug resistant mutants of HIV-1 proteasex-ray diffractionC, D, E, F——
1EBWHIV-1 protease in complex with the inhibitor BEA322x-ray diffractionA, B——
1EBWHIV-1 protease in complex with the inhibitor BEA322x-ray diffractionA, B——
1EBYHIV-1 protease in complex with the inhibitor BEA369x-ray diffractionA, B——
1EBYHIV-1 protease in complex with the inhibitor BEA369x-ray diffractionA, B——
1EBZHIV-1 protease in complex with the inhibitor BEA388x-ray diffractionA, B——
1EBZHIV-1 protease in complex with the inhibitor BEA388x-ray diffractionA, B——
1EC0HIV-1 protease in complex with the inhibitor bea403x-ray diffractionA, B——
1EC0HIV-1 protease in complex with the inhibitor BEA403x-ray diffractionA, B——
1EC1HIV-1 protease in complex with the inhibitor BEA409x-ray diffractionA, B——
1EC1HIV-1 protease in complex with the inhibitor BEA409x-ray diffractionA, B——
1EC2HIV-1 protease in complex with the inhibitor BEA428x-ray diffractionA, B——
1EC2HIV-1 protease in complex with the inhibitor BEA428x-ray diffractionA, B——
1EC3HIV-1 protease in complex with the inhibitor MSA367x-ray diffractionA, B——
1EC3HIV-1 protease in complex with the inhibitor MSA367x-ray diffractionA, B——
1EETHIV-1 reverse transcriptase in complex with the inhibitor MSC204x-ray diffractionA, B——
1EETHIV-1 reverse transcriptase in complex with the inhibitor MSC204x-ray diffractionA, B——
1HBVA check on rational drug design. crystal structure of a complex of HIV-1 protease with a novel…x-ray diffractionA, B——
1HBVA check on rational drug design. crystal structure of a complex of HIV-1 protease with a novel…x-ray diffractionA, B——
1HEFThe crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to…x-ray diffractionE——
1HEFThe crystal structures at 2.2 ångströms resolution of hydroxyethylene- based inhibitors bound to…x-ray diffractionE——
1HEGThe crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to…x-ray diffractionE——
1HEGThe crystal structures at 2.2 ångströms resolution of hydroxyethylene- based inhibitors bound to…x-ray diffractionE——
1HIHComparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with cgp…x-ray diffractionA, B——
1HIHComparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with cgp…x-ray diffractionA, B——
1HMVThe structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1x-ray diffractionA, B, C, D, E, F, G, H——
1HMVThe structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1x-ray diffractionA, B, C, D, E, F, G, H——
1HNIStructure of HIV-1 reverse transcriptase in a complex with the nonnucleoside inhibitor alpha-apa R…x-ray diffractionA——
1HNIStructure of HIV-1 reverse transcriptase in a complex with the nonnucleoside inhibitor alpha-apa R…x-ray diffractionA——
1HNVStructure of HIV-1 RT(SLASH)TIBO R 86183 complex reveals similarity in the binding of diverse…x-ray diffractionA, B——
1HNVStructure of HIV-1 RT(SLASH)TIBO R 86183 complex reveals similarity in the binding of diverse…x-ray diffractionA, B——
1HOSInhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate synthesis and…x-ray diffractionA, B——
1HOSInhibition of human immunodeficiency virus-1 protease by a C2- symmetric phosphinate synthesis and…x-ray diffractionA, B——
1HPSRational design, synthesis and crystallographic analysis of a hydroxyethylene-based HIV-1 protease…x-ray diffractionA, B——
1HPSRational design, synthesis and crystallographic analysis of a hydroxyethylene-based HIV-1 protease…x-ray diffractionA, B——
1HPZHuman immunodeficiency virus type 1x-ray diffractionA, B——
1HPZHuman immunodeficiency virus type 1x-ray diffractionA, B——
1HQEHuman immunodeficiency virus type 1x-ray diffractionA, B——
1HQEHuman immunodeficiency virus type 1x-ray diffractionA, B——

557 records more on the page itself.

Ligands

  • SO4 · Sulfate ion · in 100 records
  • MG · Magnesium ion · in 98 records
  • FRU · beta-D-fructofuranose · in 27 records
  • GLC · alpha-D-glucopyranose · in 27 records
  • MN · Manganese (II) ion · in 14 records
  • DTP · 2'-deoxyadenosine 5'-triphosphate · in 12 records
  • CA · Calcium ion · in 10 records
  • D4T · 2',3'-dehydro-2',3'-deoxy-thymidine 5'-triphosphate · in 10 records
  • K5C · 4-({4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl) amino]piperidin-1-yl}methyl)benzene-1-sulfonamide · in 10 records
  • T27 · 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile · in 8 records
  • CL · Chloride ion · in 7 records
  • K5A · 4-[(4-{[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino}piperidin-1-yl)methyl]benzene-1-sulfonamide · in 7 records
  • CD · Cadmium ion · in 6 records
  • NH4 · Ammonium ion · in 6 records
  • NVP · 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one · in 6 records
  • M9A · 5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) ethoxy]phenoxy}-7-fluoronaphthalene-2-carbonitrile · in 5 records
  • 3IR · (1~{R},2~{R})-2-phenyl-~{N}-(1,3-thiazol-2-yl) cyclopropane-1-carboxamide · in 4 records
  • 9HY · N-(6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)-N-methylacetamide · in 4 records
  • 9J1 · N-(6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)-N-methylpropanamide · in 4 records
  • 9KD · N-(6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)prop-2-enamide · in 4 records
  • 9W3 · 4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino}-6-[3-(morpholin-4-yl)propoxy]-1,3,5-triazin-2-yl) amino]benzonitrile · in 4 records
  • DDS · 2',3'-dideoxyadenosine triphosphate · in 4 records
  • H9Y · 8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile · in 4 records
  • NA · Sodium ion · in 4 records
  • RFE · L-Methionine Tenofovir · in 4 records
  • 2KW · 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile · in 3 records
  • 7AY · 5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile · in 3 records
  • 7N1 · 5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) ethoxy]-4-fluorophenoxy}-7-fluoronaphthalene-2-carbonitrile · in 3 records
  • 9JP · N-(6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)-2-fluoro-N-methylacetamide · in 3 records
  • PO4 · Phosphate ion · in 3 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.